Are Astrocytes Central Players in the Pathophysiology of Multiple Sclerosis?
Jacques De Keyser, MD;
Esther Zeinstra, MD;
Elliot Frohman, MD
Arch Neurol. 2003;60:132-136.
An interaction between antimyelin T cells and antigen-presenting glial cells is a crucial step in the cascade of immune events that lead to the inflammatory lesions in multiple sclerosis (MS). One of the most debated and controversial issues is whether microglial cells or astrocytes are the key players in initiating the (auto)immune reactions in the central nervous system in MS. Many investigators consider microglia to be the responsible intrinsic immunoeffector cells. In this review, we speculate that in MS astrocytes may serve as primary (facultative) antigen-presenting cells due to a failure of noradrenergic suppression of class II major histocompatibility complex molecules, which is caused by a loss of  2-adrenergic receptors. If this hypothesis is correct, pharmacologic suppression of the antigen-presenting capacities of astrocytes may be a potential therapy for MS.
From the Departments of Neurology, Academisch Ziekenhuis Groningen, Groningen, the Netherlands (Drs De Keyser and Zeinstra), and University of Texas Southwestern Medical Center at Dallas (Dr Frohman).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study
Mostert et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1027-1031.
ABSTRACT
| FULL TEXT
Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions
Frohman et al.
Arch Neurol 2005;62:1345-1356.
ABSTRACT
| FULL TEXT
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure
Yang et al.
Physiol. Genomics 2004;17:157-169.
ABSTRACT
| FULL TEXT
|
